Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody. 1990

L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
Department of Obstetrics and Gynecology, University Hospital Nijmegen, The Netherlands.

The safety and diagnostic accuracy of immunoscintigraphy with the indium-111-labeled monoclonal antibody OV-TL 3 F(ab')2(111In-OV-TL 3 F(ab')2) for diagnosis and follow-up of ovarian cancer was prospectively studied in 31 patients. Planar and SPECT scintigraphy were performed up to 4 days after i.v. injection of 140 MBq 111In-OV-TL 3 F(ab')2. Surgical evaluation was possible in 22 out of 31 patients. Imaging results were compared with X-ray computed tomography, ultrasound, and CA 125 serum level using the histologically confirmed surgical findings as a "gold standard." Apart from a transient rash observed in two patients, no other immediate or delayed adverse reactions were observed. Within the surgically evaluated group, ovarian cancer lesions were detected in 16 out of 17 patients (94%). Of 45 distinct tumor deposits found at operation, 67% were detected and localized with immunoscintigraphy while X-ray computed tomography and ultrasound visualized 53% and 23%, respectively.

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D007205 Indium Radioisotopes Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes. Radioisotopes, Indium
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
January 1992, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
July 1993, Archives of surgery (Chicago, Ill. : 1960),
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
April 1994, Kaku igaku. The Japanese journal of nuclear medicine,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
August 1992, Cancer,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
August 1994, Diseases of the colon and rectum,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
February 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
August 1988, Japanese journal of cancer research : Gann,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
February 1994, Journal of the Royal College of Surgeons of Edinburgh,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
July 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
L F Massuger, and P Kenemans, and R A Claessens, and R H Verheijen, and C P Schijf, and S P Strijk, and L G Poels, and R G van Hoesel, and F H Corstens
March 1995, Radiology,
Copied contents to your clipboard!